- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
More ▼
Key statistics
As of last trade, Bio Rad Laboratories Inc (BIO:NYQ) traded at 289.02, 10.49% above the 52 week low of 261.59 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 286.04 |
---|---|
High | 289.11 |
Low | 284.05 |
Bid | 288.02 |
Offer | 289.11 |
Previous close | 280.13 |
Average volume | 233.26k |
---|---|
Shares outstanding | 33.61m |
Free float | 25.07m |
P/E (TTM) | -- |
Market cap | 9.42bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 14:33 BST.
More ▼